JUL 09, 2019 10:05 AM PDT

Cardiovascular Risks And Ehlers-Danlos Syndrome

WRITTEN BY: Abbie Arce

Ehlers-Danlos Syndrome (EDS) affects the body’s connective tissues. These tissues are proteins that provide support for the gums, ligaments, organs, blood vessels, and more.

Defects in these tissues, often result in hypermobility of the joints and hyperextensibility of the skin. This means that the joints are less stable and more prone to injury. The skin of EDS patients may be soft and fragile. They may develop wounds that heal slowly or that reopen after having healed. Specific symptoms depend on the type of EDS a person has. 

Symptoms of the syndrome include chronic musculoskeletal pain, gum disease, or even mitral valve prolapse in the heart. One of the EDS subtypes may also lead to a rupture in the blood vessels, uterus, or intestines. These complications can be fatal if a large vessel ruptures.

EDS is a genetic disorder resulting from mutations in any of 19 genes. Some of the 13 EDS forms are inherited, with parents passing an abnormal gene to their offspring. The risk of passing on the condition ranges from 25 to 50%, depending on the condition subtype.

To diagnose the EDS, doctors will generally perform a physical exam, including any family or medical history. Usually, the classic symptoms of skin and joint concerns, coupled with any positive family history, is enough to make a diagnosis. 

If there is a doubt that EDS is the cause of a patient’s symptoms, doctors may take a genetic sample to confirm. It is much more likely a person has joint hypermobility, which affects 1 in 30 people, then it is to have EDS, which affects about 1 in 5000.

If EDS is confirmed, several treatment options will be explored. Because EDS is the name for a group of conditions, and not a single diagnosis, treatment has to be carefully tailored to each patient.

Some patients may be able to manage their condition with lifestyle changes effectively. These changes might include avoiding high-impact and contact sports. 

Unfortunately, this may not be sufficient treatment for everyone. Other options include physical or occupational therapy, gentle exercise, pain medication, or surgery. 

The above video from Mayo Clinic goes into detail about EDS. 

 

Sources: National Institutes of HealthMayo Clinic

About the Author
  • Abbie is an AFAA certified personal trainer and fitness instructor with an interest in all things health-science. She has recently graduated with her BS in Applied Sport and Exercise Science from Barry University in Miami. Next, she intends to earn an MPH with a focus in Epidemiology.
You May Also Like
JUL 02, 2020
Cardiology
Managing the Mitochondria After a Heart Attack
JUL 02, 2020
Managing the Mitochondria After a Heart Attack
Heart attacks are an unfortunately common occurrence across the country. One of the biggest consequences of a heart atta ...
JUL 09, 2020
Cardiology
Broken Heart Syndrome Found to Increase During Pandemic
JUL 09, 2020
Broken Heart Syndrome Found to Increase During Pandemic
Reporting in JAMA Network Open, scientists have found that broken heart syndrome, called stress cardiomyopathy, has been ...
AUG 15, 2020
Cardiology
Following Platelets to Diagnose Myocarditis
AUG 15, 2020
Following Platelets to Diagnose Myocarditis
The heart is a sensitive thing, prone not just to metaphorical heartbreak, but genuine issues if not taken care of. Myoc ...
AUG 25, 2020
Drug Discovery & Development
Blood-Pressure Medications Lower The Risk of Depression
AUG 25, 2020
Blood-Pressure Medications Lower The Risk of Depression
Do commonly prescribed blood pressure medications increase the risk of depression? The answer is No—according to a ...
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
Loading Comments...